Urological Devices | Market Insights | US | 2024
Driven by product innovation, rising kidney stone prevalence, and an aging population, the market for US urological devices will grow at a modest rate through 2032 despite the significant impact of the COVID-19 pandemic during 2020-2022. Going forward, favorable demographic trends, an increasing prevalence of obesity, adoption of premium devices, and the growing availability of less invasive treatment options will support the growth of urology procedure volumes. Moreover, the continued shift toward value-based health care in the US will drive demand for minimally invasive treatments that not only provide improved efficacy, but also reduced postoperative pain and shorter recovery periods.
This Medtech 360 Report provides comprehensive data and analysis on the state of the US urological device market from 2019 through 2032.
